Table 2.
Total consumption of hypnotics (in Defined Daily Doses, DDDs), as assessed according to the wholesale data and the Drug Prescription Register for N05C drugs used in outpatient care during 2005-2010.
| Year | Total consumption of N05C drugs DDD (million) | Reimbursed consumption of N05C drugs DDD (million) | Coverage % of reimbursed consumption of N05C drugs from total consumption | N. of persons receiving reimbursement for N05C drugs |
|---|---|---|---|---|
| 2005 | 96.9 | 66.7 | 68.9 | 252.684 |
| 2006° | 96.5 | 73.9 | 76.5 | 308.331 |
| 2007 | 97.8 | 77.4 | 79.2 | 334.180 |
| 2008 | 97.4 | 77.6 | 79.7 | 342.073 |
| 2009 | 93.0 | 79.5 | 85.5 | 369.871 |
| 2010 | 87.5 | 75.4 | 86.2 | 356.192 |
°At the beginning of 2006, the method of calculating reimbursement payments in the Finnish insurance system changed. With the reform, the fixed non-reimbursable sum paid by the patient per purchase (≤10 euros) was abandoned. In the new system, the reimbursement payment is calculated separately for each medical product and almost every purchase of N05C drugs (with approved reimbursement status) can thereby be found in the drug prescription register.